Schrenk, C.;                     Bollmann, L.M.;                     Haist, C.;                     Bister, A.;                     Wiek, C.;                     Wecker, M.;                     Roth, D.;                     Petzsch, P.;                     Köhrer, K.;                     Hamacher, A.;     
    et al.    Synergistic Interaction of the Class IIa HDAC Inhibitor CHDI0039 with Bortezomib in Head and Neck Cancer Cells. Int. J. Mol. Sci. 2023, 24, 5553.
    https://doi.org/10.3390/ijms24065553
    AMA Style
    
                                Schrenk C,                                 Bollmann LM,                                 Haist C,                                 Bister A,                                 Wiek C,                                 Wecker M,                                 Roth D,                                 Petzsch P,                                 Köhrer K,                                 Hamacher A,         
        et al.        Synergistic Interaction of the Class IIa HDAC Inhibitor CHDI0039 with Bortezomib in Head and Neck Cancer Cells. International Journal of Molecular Sciences. 2023; 24(6):5553.
        https://doi.org/10.3390/ijms24065553
    
    Chicago/Turabian Style
    
                                Schrenk, Christian,                                 Lukas M. Bollmann,                                 Corinna Haist,                                 Arthur Bister,                                 Constanze Wiek,                                 Maria Wecker,                                 Dennis Roth,                                 Patrick Petzsch,                                 Karl Köhrer,                                 Alexandra Hamacher,         
         and et al.        2023. "Synergistic Interaction of the Class IIa HDAC Inhibitor CHDI0039 with Bortezomib in Head and Neck Cancer Cells" International Journal of Molecular Sciences 24, no. 6: 5553.
        https://doi.org/10.3390/ijms24065553
    
    APA Style
    
                                Schrenk, C.,                                 Bollmann, L. M.,                                 Haist, C.,                                 Bister, A.,                                 Wiek, C.,                                 Wecker, M.,                                 Roth, D.,                                 Petzsch, P.,                                 Köhrer, K.,                                 Hamacher, A.,                                 Hanenberg, H.,                                 Fluegen, G.,                                 & Kassack, M. U.        
        
        (2023). Synergistic Interaction of the Class IIa HDAC Inhibitor CHDI0039 with Bortezomib in Head and Neck Cancer Cells. International Journal of Molecular Sciences, 24(6), 5553.
        https://doi.org/10.3390/ijms24065553